4/17/25 Double Medical Jeopardy

DAPT Duration

100

high-risk TIA or minor stroke

3 weeks

200

s/p mechanical thrombectomy

3 months

300

intracranial large artery atherosclerosis with stenosis 70-99% whether TIA or ischemic stroke

up to 90 days

400

ACC/AHA: minimum after DES (drug eluting stent) placed

6 months of DAPT for patients with stable ischemic heart disease (SIHD) 

12 months for those with acute coronary syndromes

500

ACC/AHA: minimum after BMS (bare metal stent) placed

1 month

Infant Formulas/Milk

100

indication for soy based formula

Galactosemia

Parent vegetarian and doesn’t want animal products for babies

• Soy sequesters calcium and phosphorus from being absorbed
• Dont use with babies that have cow protein allergy

200

kcal/oz nutritional requirement for full term babies

19-20

300

name a formula you can give for cow protein intolerance

extensively hydrolyzed

or

AA based formula

400

Length of time/number of missed feeds considered sleeping through the night

5-6 hr (missing 1-2 feeds)

500

Indication for whey formula

GER (gastroesophageal reflux)

AR (anti reflux)

Stroke Secondary Prevention

100

Target BP goal

<130/80

200

Target LDL

<70

300

A1c goal

≤7%

400

Treatment if LDL-C ≥70 mg/dL despite statin

ezetimibe or PCSK9 inhibitor

500

Initial anti thrombotic therapy for large infarct with cardioembolic source

ASA monotherapy (switch to OA after 1-2 weeks if stable) due to risk of hemorrhagic transformation

Asthma

100

GINA: preferred initial regimen in mild asthma (step 1-2)

PRN symbicort (ICS-formoterol)

200

GINA: step up therapy if uncontrolled with regimen in step 1-2

SMART/MART (single maintenance and reliever therapy) with symbicort

SMART means it's the controller and PRN inhaler

300

Preferred method of diagnosing asthma in athletes

bronchial provocation testing 

(starts with a very small dose of methacholine and, depending on your response, the doses will be increased until either you experience 20 percent drop in breathing ability, or you reach a maximum dose with no change in your lung function)

400

GINA: What is considered SABA overuse

3 or more 200 dose-containers/yr (associated with inc risk of exacerbations, inc mortality especially if 1 or more canister/month)

500

GINA: For a patient already taking ICS-containing treatment with variable respiratory symptoms but no variable airflow limitation, how long should you hold inhalers before considering repeat spirometry (will accept answer for SABA, twice daily ICS-LABA, and once-daily ICS-LABA

4 hr for SABA

24 hr for twice daily ICS-LABA

36 hr for once daily ICS-LABA

COPD

100

FEV1/FVC consistent with it

<0.7

200

preferred treatment for COPD GOLD Group A (give class and example of medication)

LABA (salmeterol, formoterol)

or 

LAMA (tiotropium)

300

Preferred treatment for COPD GOLD Group B and E

LABA+LAMA

400

When to consider LABA+LAMA+ICS in group E

if blood eosinophils > 300

if uncontrolled on LABA+LAMA (and inhaling appropriately)

500

Name a criteria to be diagnosed with COPD Group E

2 or more moderate exacerbations in a year (moderate = requiring steroids)

1 or more hospitalizations w/in past year